Related Experiment Video
Updated: Oct 13, 2026

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Missense mutants inactivate guanosine triphosphate cyclohydrolase I in hereditary progressive dystonia
1Department of Medical Genetics, Nara Medical University, Shijo-cho 840, Kashihara, 634-8521, Nara, Japan. sueno@nmu-gw.cc.naramed-u.ac.jp
Abstract:
Hereditary progressive dystonia (HPD) with marked diurnal fluctuation is caused by mutant guanosine triphosphate (GTP) cyclohydrolase I (GCH). The clinical presentation of dominant HPD varies considerably. We proposed the hypothesis that a relative increase of mutant GCH capable of inhibiting normal GCH is responsible for heterogeneous phenotypic manifestations. In a Japanese family with a novel G90V mutation, an affected heterozygote had a higher mutant/normal mRNA ratio than an unaffected heterozygote. Co-expression analysis showed that mutant enzyme (GCH-G90V) inactivated the normal enzyme in the COS cells. Similarly, GCH-G203R showed the dominant negative effects. These results supported our proposed hypothesis.
Related Concept Videos
Huntington Disease l: Introduction
Incomplete Dominance
Alterations in Muscle Tone lll
Alterations in Muscle Tone ll
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...

